BRANDON LARSEN: Open Payments
NPI 1215523337 · IDAHO FALLS, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,395 in 51 payments from 9 companies in 2025. Trend: 2023 $1,521 · 2024 $1,374 · 2025 $1,395
Food & beverage: $1,395
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 10 | $317 |
| ABBVIE INC. | 13 | $292 |
| E.R. Squibb & Sons, L.L.C. | 2 | $249 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 18 | $240 |
| Supernus Pharmaceuticals, Inc. | 1 | $125 |
| Janssen Pharmaceuticals, Inc | 2 | $93 |
| Otsuka America Pharmaceutical, Inc. | 3 | $49 |
| Alkermes, Inc. | 1 | $16 |
| Neurocrine BioSciences, Inc. | 1 | $15 |
Products named: FANAPT, COBENFY, CAPLYTA, VRAYLAR, Qelbree, INVEGA SUSTENNA, ABILIFY ASIMTUFII, VIVITROL.
Industry payments across ID — which companies pay providers there.
